[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345267-105":59,"doc-detail-345267-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","methylation-entropy-as-a-novel-dimension-in-liquid-biopsy-enhanced-multimodal-framework-for-cancer-detection-and-tissue-oforigin-classification","Methylation entropy as a novel dimension in liquid biopsy - enhanced multimodal framework for cancer detection and tissue-oforigin classification","","Circulating cell-free DNA (cfDNA) serves as a promising biomarker for non-invasive early cancer detection. The study integrates methylation entropy, reflecting DNA methylation heterogeneity, with additional cfDNA features in a multimodal model to strengthen multi-cancer detection. A HYGEIA custom methylation panel is developed using informative CpG sites, validated for performance, and used to compute fragment-level methylation entropy. Deep targeted bisulfite sequencing is performed on 521 plasma samples, followed by training and testing for an enhanced early detection model and a tissue-of-origin classifier across seven cancer types.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/methylation-entropy-as-a-novel-dimension-in-liquid-biopsy-enhanced-multimodal-framework-for-cancer-detection-and-tissue-oforigin-classification/345267/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/methylation-entropy-as-a-novel-dimension-in-liquid-biopsy-enhanced-multimodal-framework-for-cancer-detection-and-tissue-oforigin-classification/345267.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the role of methylation entropy in the study?","Question",{"text":112,"@type":113},"Methylation entropy is used as a measure of cfDNA methylation heterogeneity and incorporated into the multimodal model to improve multi-cancer detection and classification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the HYGEIA panel used in the research workflow?",{"text":117,"@type":113},"The HYGEIA panel containing informative methylation CpG sites was developed and validated, then used with deep panel-targeted bisulfite sequencing to compute fragment-level methylation entropy from plasma samples.",{"name":119,"@type":110,"acceptedAnswer":120},"What performance did the enhanced models achieve?",{"text":121,"@type":113},"A methylation-entropy-only classifier reached an AUC of 0.938 in the testing set. The enhanced multi-cancer early detection (EMCED) model achieved an AUC of 0.979, and the tissue-of-origin (TOO) model reached 92.3% accuracy among cancer cases.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345267,1790248909,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Jia et al. Journal of Translational Medicine (2026) 24:597  \n[https://doi.org/10.1186/s12967-026-08028-x](https://doi.org/10.1186/s12967-026-08028-x)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nMethylation entropy as a novel dimension in liquid biopsy: enhanced multimodal framework for cancer detection and tissue-oforigin classification  \nXiaoqiong Jia1†, Yongjun Li2†, Baochen Du2,3†, Jie Zhao2†, Xiuxiu Wang2†, Hong Yang1,4, Qiang Zhao4, Qin Si1, Yuanyuan Guo2, Bateer Han1, Zhenghang Wang1,4, Junqing Liang1, Yongfei Peng2, Shuanping Liu2, Guangpeng Zhou2, Zhongwu Li1*, Ziyu Li4*, Xiangdong Fang3* and Xiaoliang Han2*  \nAbstract  \nBackground Circulating cell-free DNA (cfDNA) is a promising biomarker for non-invasive early cancer detection. We integrated methylation entropy, a measure of DNA methylation heterogeneity, with other cfDNA features into amultimodal model to improve multi-cancer detection.  \nMethods A customized panel named HYGEIA, containing abundant informative methylation CpG sites, was first developed. The panel’s performance was validated, and a method for calculating fragment-level methylation entropy was established. Subsequently, this panel was utilized to perform deep panel-targeted bisulfite sequencing on 521 plasma samples from 288 cancer patients and 233 non-cancer individuals. Participants were randomly allocated into training (197 cancer, 157 non-cancer) and testing (91 cancer, 76 non-cancer) sets for constructing the Enhanced Multi-Cancer Early Detection (EMCED) model. Upon validation of the EMCED model, aTissue-of-Origin (TOO) model was further developed and evaluated across seven cancer types.  \nResults A classifier based solely on methylation entropy achieved an AUC of 0.938 (sensitivity 78 . 0%, specificity 94. 7%) in the testing set for multi-cancer detection. Building on this, two additional characteristics, DNA methylation levels and fragmentation features, were integrated into the model, resulting in the EMCED model, which achieved  \n\n| †Xiaoqiong Jia, Yongjun Li, Baochen Du, Jie Zhao and Xiuxiu Wang contributed equally to this work. |\n| --- |\n| Lead contact: Xiaoliang Han |\n\n*Correspondence: Zhongwu Li [zhwuli@hotmail.com](zhwuli@hotmail.com)[ ](zhwuli@hotmail.com)Ziyu Li [ziyu_li@hsc.pku.edu.cn](ziyu_li@hsc.pku.edu.cn)[ ](ziyu_li@hsc.pku.edu.cn)Xiangdong Fang [fangxd@big.ac.cn](fangxd@big.ac.cn)[ ](fangxd@big.ac.cn)Xiaoliang Han [sean.han@biochainbj.com](sean.han@biochainbj.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nJia et al. Journal of Translational Medicine (2026) 24:597 Page 2 of 17  \nan AUC of 0.979 (sensitivity 93.4%, specificity 93.4%) in the testing set. Analysis of the EMCED model’s sensitivity by cancer type showed detection rates of 95 . 5% for colorectal cancer, 98 . 0% for lung cancer, 93. 5% for gastric cancer, 83. 8% for ovarian cancer, and 100% for liver, esophageal, and thyroid cancers. The TOO model, which incorporated all three feature types, methylation entropy, methyla","cbCaikV0rhdmBu7v","https://ap.wps.com/l/cbCaikV0rhdmBu7v","pdf",4123445,17,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What is the role of methylation entropy in the study?\",\"answer\":\"Methylation entropy is used as a measure of cfDNA methylation heterogeneity and incorporated into the multimodal model to improve multi-cancer detection and classification.\"},{\"question\":\"How was the HYGEIA panel used in the research workflow?\",\"answer\":\"The HYGEIA panel containing informative methylation CpG sites was developed and validated, then used with deep panel-targeted bisulfite sequencing to compute fragment-level methylation entropy from plasma samples.\"},{\"question\":\"What performance did the enhanced models achieve?\",\"answer\":\"A methylation-entropy-only classifier reached an AUC of 0.938 in the testing set. The enhanced multi-cancer early detection (EMCED) model achieved an AUC of 0.979, and the tissue-of-origin (TOO) model reached 92.3% accuracy among cancer cases.\"}]","Methylation entropy as a novel dimension in liquid biopsy - enhanced multimodal framework for cancer detection and tissue-oforigin classification | PDF",1790057021,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e1e6648edcbbcf5a307520cea7f2855.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d9c3dfc96a7b8b2ac061a02981cbf21.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d06f4ed57325d204dde4c0340dfc6c72.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4a96480021bb1d14edfe2ba25c9d032.webp",980,1306]